TENET HEALTHCARE CORP - Common Stock (THC)

Historical Holders from Q1 2014 to Q3 2025

Symbol
THC on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
95.4M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
83.5M
Holdings value
$17B
% of all portfolios
0.017%
Grand Portfolio weight change
-0.001%
Number of holders
667
Number of buys
325
Number of sells
-321
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.007%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TENET HEALTHCARE CORP - Common Stock (THC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.8% $1.02B 8.39M BlackRock, Inc. 31 Mar 2025
Invesco Ltd. 4.4% $509M 4.17M Invesco Ltd. 31 Mar 2025

Institutional Holders of TENET HEALTHCARE CORP - Common Stock (THC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 83.5M $17B -$575M $203.04 667
2025 Q2 86.7M $15.3B -$242M $176.00 619
2025 Q1 88.1M $11.8B -$298M $134.50 557
2024 Q4 90.8M $11.5B +$75M $126.23 571
2024 Q3 88.9M $14.8B -$389M $166.20 596
2024 Q2 92.1M $12.2B -$231M $133.03 522
2024 Q1 94M $9.88B +$21M $105.11 448
2023 Q4 95.1M $7.18B -$62M $75.57 420
2023 Q3 96M $6.33B -$70.2M $65.89 405
2023 Q2 95.8M $7.79B -$238M $81.38 410
2023 Q1 99.4M $5.9B -$261M $59.42 359
2022 Q4 105M $5.11B -$189M $48.79 349
2022 Q3 108M $5.57B +$91.5M $51.58 346
2022 Q2 106M $5.56B -$63.8M $52.56 347
2022 Q1 105M $9.05B +$283M $85.96 388
2021 Q4 103M $8.37B +$119M $81.69 361
2021 Q3 101M $6.71B +$55.8M $66.44 326
2021 Q2 100M $6.72B +$247M $66.99 314
2021 Q1 97.4M $5.07B -$60.3M $52.00 299
2020 Q4 99.1M $3.96B -$64.3M $39.93 264
2020 Q3 102M $2.5B +$7.05M $24.51 234
2020 Q2 102M $1.85B +$1.24M $18.11 224
2020 Q1 105M $1.51B -$62.6M $14.40 240
2019 Q4 104M $3.93B -$213M $38.03 256
2019 Q3 110M $2.43B +$92.5M $22.12 235
2019 Q2 106M $2.19B +$35.5M $20.66 235
2019 Q1 104M $2.99B +$15.1M $28.84 251
2018 Q4 104M $1.79B -$127M $17.14 254
2018 Q3 109M $3.1B +$63.3M $28.46 250
2018 Q2 106M $3.57B -$166M $33.57 242
2018 Q1 112M $2.72B -$112M $24.25 227
2017 Q4 120M $1.82B -$114M $15.16 223
2017 Q3 128M $2.1B +$145M $16.43 233
2017 Q2 117M $2.27B +$91.4M $19.34 234
2017 Q1 113M $2B +$459M $17.71 241
2016 Q4 102M $1.51B +$4.38M $14.84 247
2016 Q3 99M $2.24B -$49.4M $22.66 253
2016 Q2 100M $2.77B -$40.4M $27.64 249
2016 Q1 101M $2.93B -$50.7M $28.93 261
2015 Q4 103M $3.11B -$26.5M $30.30 268
2015 Q3 101M $3.74B +$37.7M $36.92 303
2015 Q2 98.2M $5.68B +$36.9M $57.88 327
2015 Q1 98.2M $4.86B +$154M $49.51 303
2014 Q4 95M $4.81B -$57.7M $50.67 313
2014 Q3 95.5M $5.67B -$56.8M $59.39 306
2014 Q2 97.3M $4.57B +$16.3M $46.94 284
2014 Q1 98.6M $4.22B +$260M $42.81 282